FdaApplication
ANDA 215041
Identifiers
- fda_app_no: ANDA215041
Properties
| Property | Value |
|---|---|
| applicant_name | NOVITIUM PHARMA LLC |
| application_type | ANDA |
| approval_date | 2021-12-17 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RIFABUTIN | RIFABUTIN | 150MG | CAPSULE;ORAL |
1 product